Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families.

BMC medical genetics - 13 Aug 2013

Haanpää Maria, Pylkäs Katri, Moilanen Jukka S, Winqvist Robert

Abstract excerpt

BACKGROUND: Testing for mutations in the BRCA1 and BRCA2 genes among high-risk breast cancer patients has become a routine practice among clinical geneticists. Unfortunately, however, the genetic background of a majority of the cases coming to the clinics remains currently unexplained, making genetic counseling rather challenging. In recent years it has become evident world-wide that also women carrying a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Fanconi Anemia Complementation Group N Protein

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Finland

Share to Germ-Line Mutation

Share to Nuclear Proteins

Share to Tumor Suppressor Proteins

Share to Ubiquitin-Protein Ligases

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 23941127
DOI: 10.1186/1471-2350-14-82
PMCID: PMC3751431

Genes

PALB2
BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families.PMID 23941127Read ↗

Penetrance analysis of the PALB2 c.1592delT founder mutation.Semantic proximity Read ↗

A recurrent mutation in PALB2 in Finnish cancer families.Semantic proximity Read ↗

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.Semantic proximity Read ↗

Evidence against PALB2 involvement in Icelandic breast cancer susceptibility.Semantic proximity Read ↗

PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland.Semantic proximity Read ↗

PALB2 variants in hereditary and unselected Finnish prostate cancer cases.Semantic proximity Read ↗

Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.Semantic proximity Read ↗

Mutation analysis of PALB2 gene in French breast cancer families.Semantic proximity Read ↗

PALB2: research reaching to clinical outcomes for women with breast cancerSemantic proximity Read ↗

The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.Semantic proximity Read ↗

PALB2 sequence variants in young South African breast cancer patients.Semantic proximity Read ↗

Rare germline mutations in PALB2 and breast cancer risk: a population-based study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.